Insider Transactions in Q2 2022 at Vir Biotechnology, Inc. (VIR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,991
-3.35%
|
$119,784
$24.89 P/Share
|
|
Jun 09
2022
|
Robert J More Director |
BUY
Other acquisition or disposition
|
Indirect |
3,374
+0.68%
|
-
|
|
Jun 09
2022
|
Robert J More Director |
SELL
Other acquisition or disposition
|
Direct |
3,374
-7.95%
|
-
|
|
Jun 08
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,684
+8.98%
|
-
|
|
Jun 08
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
27,489
+8.52%
|
-
|
|
Jun 08
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.71%
|
-
|
|
Jun 08
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
2,952
+8.54%
|
-
|
|
Jun 08
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
14,551
+8.48%
|
-
|
|
Jun 08
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.71%
|
-
|
|
Jun 08
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-0.59%
|
$465,790
$26.17 P/Share
|
|
Jun 02
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
17,502
+9.26%
|
-
|
|
Jun 02
2022
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.64%
|
-
|
|
Jun 02
2022
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
29,173
+9.34%
|
-
|
|
Jun 02
2022
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
500,000
-2.64%
|
-
|
|
May 24
2022
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
1,687
-17.25%
|
$38,801
$23.82 P/Share
|
|
May 24
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
3,374
-0.22%
|
$77,602
$23.82 P/Share
|
|
May 23
2022
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+39.58%
|
-
|
|
May 23
2022
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+39.58%
|
-
|
|
May 23
2022
|
Robert J More Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+13.11%
|
-
|
|
May 23
2022
|
Robert J Perez Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+39.58%
|
-
|
|
May 23
2022
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+0.42%
|
-
|
|
May 23
2022
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+39.58%
|
-
|
|
May 23
2022
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+39.58%
|
-
|
|
May 23
2022
|
Phillip A Sharp Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+5.27%
|
-
|
|
May 23
2022
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,405
+2.46%
|
-
|
|
May 09
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
14,541
-0.96%
|
$290,820
$20.62 P/Share
|
|
Apr 28
2022
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
17,915
-0.58%
|
$376,215
$21.12 P/Share
|
|
Apr 15
2022
|
Phillip Pang EVP & Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
7,777
-4.96%
|
-
|